Suchergebnisse - "Alonso-Gordoa, Teresa"

PubPharm (93)

1

Obinutuzumab Pretreatment as a Novel Approach to Mitigate Formation of Anti-Drug Antibodies Against Cergutuzumab Amunaleukin in Patients with Solid Tumors

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Peters, S. | Angevin, E. | Alonso-Gordoa, T. | +22

2

A Signal-finding Study of Abemaciclib in Heavily Pretreated Patients with Metastatic Castration-Resistant Prostate Cancer : Results from CYCLONE 1

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Agarwal, N. | Castellano, D. | Alonso-Gordoa, T. | +16

3

Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer

enthalten in: The New England journal of medicine | 2024

von Powles, T. | Valderrama, B. | Gupta, S. | +122

4

Phase 1/2 study of monalizumab plus durvalumab in patients with advanced solid tumors

enthalten in: Journal for immunotherapy of cancer | 2024

von Patel, S. | Alonso-Gordoa, T. | Banerjee, S. | +11

5

Survival by Depth of Response and Efficacy by International Metastatic Renal Cell Carcinoma Database Consortium Subgroup with Lenvatinib Plus Pembrolizumab Versus Sunitinib in Advanced Renal Cell Carcinoma : Analysis of the Phase 3 Randomized CLEAR Study

enthalten in: European urology oncology | 2023

von Grünwald, V. | Powles, T. | Kopyltsov, E. | +17

6

Surgical and non-surgical management of thoracic and cervical paraganglioma

enthalten in: Annales d'endocrinologie | 2023

von Araujo-Castro, M. | Redondo López, S. | Pascual-Corrales, E. | +6

7

Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

enthalten in: Cells | 2023

von Gómez-Vecino, A. | Corchado-Cobos, R. | Blanco-Gómez, A. | +49

UpdateOf: bioRxiv. 2023 Jan 06;:. - PMID 36712139

8

Long-term Clinical Outcomes of a Spanish Cohort of Metastatic Renal Cell Carcinoma Patients with a Complete Response to Sunitinib

enthalten in: Clinical genitourinary cancer | 2023

von de Velasco, G. | Alonso-Gordoa, T. | Rodríguez-Vida, A. | +28

9

Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin: the phase II DUNE trial (GETNE 1601)

enthalten in: ResearchSquare.com | 2023

von Capdevila, J. | Hernando, J. | Teule, A. | +20

10

A correlative biomarker study and integrative prognostic model in chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide

enthalten in: The Prostate | 2023

von Fernandez-Perez, M. | Perez-Navarro, E. | Alonso-Gordoa, T. | +28

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]